Gene Patch Technology
Presenter: Neal Howard
Guest: Dr. Stephen Shrewsbury
Guest Bio: Dr. Shrewsbury was most recently Senior Vice President, Preclinical & Clinical Development and Chief Medical Officer of AVI BioPharma (now Sarepta Therapeutics). From 2005 until 2009, he held similar roles at Adamas Pharmaceuticals and MAP Pharmaceuticals. While at MAP, Dr. Shrewsbury lead four inhaled drug programs and took two lead candidates (in asthma and migraine) from preclinical stage to Phase III in 18 months. Prior to his experience in biotechnology, Dr. Shrewsbury spent 10 years with Glaxo and Chiron launching notable respiratory programs such as Seretide in Europe and Flovent and Advair in the US. Dr. Shrewsbury received his medical degree from the University of Liverpool, UK and spent 13 years working in the UK National Health Service before entering the pharmaceutical industry.
Key Takeaways
- Expert Profile: Dr. Stephen Shrewsbury — Dr. Shrewsbury was most recently Senior Vice President, Preclinical & Clinical Development and Chief Medical Officer of AVI BioPharma (now Sarepta Therapeutics). From 2005 until 2009, he held simil…
- Core Discussion: Dr. Stephen Shrewsbury discusses some of the ethical questions that could arise as gene patch technology progresses.
- Key Insight: Thanks so much for being with us here today.
- Clinical Perspective: Our guest in studio today is Dr.
- Why It Matters: Healthcare professionals can gain valuable insights from Dr. Stephen Shrewsbury’s expertise and experience shared on this episode.
Segment Overview
Dr. Stephen Shrewsbury discusses some of the ethical questions that could arise as gene patch technology progresses.
Transcription
Health Professional Radio
Neal Howard: Hello. You’re listening to Health Professional Radio. I’m your host, Neal Howard. Thanks so much for being with us here today. Our guest in studio today is Dr. Steven Shrewsbury. Dr. Shrewsbury has been doing research with the United Kingdom’s National Health Service. He is now a member of the pharmaceutical industry and has been for the last 20 years or so.
We’ve been talking about how these gene patches manipulate the messages that are attached to our DNA. These synthetic gene patches are medicine that specifically target strands of DNA as opposed to organs on a larger scale, and there have been approvals for these gene patches as they relate to the management of cholesterol in the body.
There’s much more research that’s being done and also more approvals that are expected down the road. In addition to research, Dr. Shrewsbury is also an author, the author of Defy Your DNA. In his book, he talks about these gene patches and how these gene patches can work to reverse the effects of aging and many of the other diseases that afflict us on a daily basis. How are you doing today, doctor?
Want to continue reading? Please log-in or register to see the Full Transcript.
Medical Disclaimer
The information provided on this website is for general informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional for medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
